| Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53 TJ Grob, U Novak, C Maisse, D Barcaroli, AU Lüthi, F Pirnia, B Hügli, ... Cell Death & Differentiation 8 (12), 1213-1223, 2001 | 466 | 2001 |
| The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas U Novak, A Rinaldi, I Kwee, SV Nandula, PMV Rancoita, M Compagno, ... Blood, The Journal of the American Society of Hematology 113 (20), 4918-4921, 2009 | 278 | 2009 |
| Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial A Davies, TE Cummin, S Barrans, T Maishman, C Mamot, U Novak, ... The Lancet Oncology 20 (5), 649-662, 2019 | 254 | 2019 |
| BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma M Saito, U Novak, E Piovan, K Basso, P Sumazin, C Schneider, M Crespo, ... Proceedings of the National Academy of Sciences 106 (27), 11294-11299, 2009 | 229 | 2009 |
| Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome A Rinaldi, M Mian, E Chigrinova, L Arcaini, G Bhagat, U Novak, ... Blood, The Journal of the American Society of Hematology 117 (5), 1595-1604, 2011 | 209 | 2011 |
| Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ... Annals of oncology 33 (12), 1250-1268, 2022 | 159 | 2022 |
| Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use U Bacher, E Shumilov, J Flach, N Porret, R Joncourt, G Wiedemann, ... Blood cancer journal 8 (11), 113, 2018 | 128 | 2018 |
| The relation between colour and structural changes in thermochromic systems comprising crystal violet lactone, bisphenol A, and tetradecanol O Panák, M Držková, M Kaplanová, U Novak, MK Gunde Dyes and Pigments 136, 382-389, 2017 | 100 | 2017 |
| HIV and human herpesvirus 8 co‐infection across the globe: systematic review and meta‐analysis E Rohner, N Wyss, Z Heg, Z Faralli, SM Mbulaiteye, U Novak, M Zwahlen, ... International journal of cancer 138 (1), 45-54, 2016 | 98 | 2016 |
| HHV-8 seroprevalence: a global view E Rohner, N Wyss, S Trelle, SM Mbulaiteye, M Egger, U Novak, ... Systematic reviews 3, 1-7, 2014 | 81 | 2014 |
| MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single … AJM Ferreri, JK Doorduijn, A Re, MG Cabras, J Smith, F Ilariucci, M Luppi, ... The Lancet Haematology 8 (2), e110-e121, 2021 | 69 | 2021 |
| Oxaliplatin‐induced immune pancytopenia BM Taleghani, S Fontana, O Meyer, N Ahrens, U Novak, MM Borner, ... Transfusion 45 (5), 704-708, 2005 | 65 | 2005 |
| Diagnosis of Burkitt lymphoma in due time: a practical approach SB Cogliatti, U Novak, S Henz, U Schmid, P Möller, TFE Barth British journal of haematology 134 (3), 294-301, 2006 | 60 | 2006 |
| Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy E Zucca, S Rondeau, A Vanazzi, B Řstenstad, UJM Mey, D Rauch, ... Blood, The Journal of the American Society of Hematology 134 (4), 353-362, 2019 | 59 | 2019 |
| Disparate expression of the PTEN gene: a novel finding in B‐cell chronic lymphocytic leukaemia (B‐CLL) N Leupin, B Cenni, U Novak, B Hügli, HU Graber, A Tobler, MF Fey British journal of haematology 121 (1), 97-100, 2003 | 58 | 2003 |
| Genetic and phenotypic attributes of splenic marginal zone lymphoma F Bonfiglio, A Bruscaggin, F Guidetti, L Terzi di Bergamo, M Faderl, ... Blood, The Journal of the American Society of Hematology 139 (5), 732-747, 2022 | 56 | 2022 |
| Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia U Novak, TJ Grob, G Baskaynak, UR Peters, S Aebi, D Zwahlen, ... Annals of oncology 12 (7), 981-986, 2001 | 56 | 2001 |
| Structural studies of TiO2/wood coatings prepared by hydrothermal deposition of rutile particles from TiCl4 aqueous solutions on spruce (Picea Abies) wood P Pori, A Vilčnik, M Petrič, AS Škapin, M Mihelčič, AŠ Vuk, U Novak, ... Applied Surface Science 372, 125-138, 2016 | 53 | 2016 |
| A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL) U Novak, E Oppliger Leibundgut, J Hager, D Mühlematter, M Jotterand, ... Blood, The Journal of the American Society of Hematology 100 (5), 1787-1794, 2002 | 51 | 2002 |
| CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas MT Mélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, Yara Banz, Zala ... Blood 127, 1780-9, 2016 | 41* | 2016 |
Thilo J. Zander, MDHead of Lymphoma and Myeloma Service, Lucerne Cancer Center LUKSVerified email at luks.ch
